Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADHD autonomic nervous system evaluation during treatment with methylphenidate or atomoxetine
2009-011887-12Phase 4Active
- Sponsor
- Praxis Prof. Koenig
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methylphenidate and atomoxetine in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Praxis Prof. Koenig. Primary endpoints: Autonomic nervous system parameters during stimulant or atomoxetine treatment, Comparison of methylphenidate versus atomoxetine effects and 3 more. Started Apr 2009; status: active.
02
Drugs
methylphenidateatomoxetine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2009-011887-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011887-12.